So-Young International Inc. Sponsored ADR (NASDAQ:SY - Get Free Report) shares were up 7.4% on Tuesday . The stock traded as high as $4.96 and last traded at $4.94. Approximately 111,105 shares traded hands during mid-day trading, a decline of 81% from the average daily volume of 596,841 shares. The stock had previously closed at $4.60.
Analyst Upgrades and Downgrades
SY has been the subject of several research reports. Wall Street Zen raised So-Young International to a "hold" rating in a research report on Friday, July 18th. Citigroup raised So-Young International from a "neutral" rating to a "buy" rating and set a $5.50 target price for the company in a research report on Tuesday, July 8th.
Read Our Latest Research Report on SY
So-Young International Price Performance
The company has a market capitalization of $500.61 million, a price-to-earnings ratio of -6.16 and a beta of 1.76. The stock has a 50 day moving average price of $9.73 and a two-hundred day moving average price of $11.94.
So-Young International (NASDAQ:SY - Get Free Report) last posted its quarterly earnings results on Friday, May 16th. The company reported ($0.60) earnings per share (EPS) for the quarter, beating the consensus estimate of ($5.10) by $4.50. The business had revenue of $40.95 million for the quarter, compared to analysts' expectations of $293.76 million. So-Young International had a negative return on equity of 2.14% and a negative net margin of 41.03%.
Hedge Funds Weigh In On So-Young International
A hedge fund recently raised its stake in So-Young International stock. Jane Street Group LLC boosted its position in So-Young International Inc. Sponsored ADR (NASDAQ:SY - Free Report) by 264.2% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 36,419 shares of the company's stock after buying an additional 26,419 shares during the quarter. Jane Street Group LLC's holdings in So-Young International were worth $30,000 as of its most recent filing with the SEC. Institutional investors and hedge funds own 35.31% of the company's stock.
About So-Young International
(
Get Free Report)
So-Young International Inc operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users medical aesthetic knowledge and experience to reach an informed medical aesthetic treatment decision and make reservations for treatment with medical professionals and medical aesthetic institutions; So-Young Beauty which provides similar interfaces and functions as the mobile app, as well as serves as additional access points to the platform; and medical aesthetic community content through its website soyoung.com.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider So-Young International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and So-Young International wasn't on the list.
While So-Young International currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.